Clinical Trial Update: Efficacy of Intralesional PRP in Treatment of Onychomycosis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating intralesional platelet-rich plasma for treatment of onychomycosis is described, with the status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Onychomycosis

Drugs mentioned

• Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Sohag University | Conditions: Platelet Rich Plasma | Phase 3 | Status: UNKNOWN